Research conducted at the Institute of Neurology of University College London (UCL) just published in the Proceedings of the National Academy of Sciences USA has identified a set of novel therapeutic targets for a subtype of Charcot-Marie-Tooth disease (CMT), a human condition that currently has no effective treatments.
Continue ReadingDr Andrew Shevchuk and his team from Imperial College London will investigate how mutations associated with some types of centronuclear myopathy and Charcot-Marie-Tooth disease (CMT)
Continue Reading
Symptoms of stumbling and balance problems led to people accusing the 29-year-old lawyer of being drunk.
Continue ReadingSeptember is the start of awareness month for Charcot Marie Tooth, a neurological disorder that affects around 23,000 people in […]
Continue ReadingTHROUGHOUT his childhood Colin Tyrie was always falling over, ripping his trousers, grazing his knees or spraining his ankles. Most […]
Continue ReadingINSPIRED by her brave loved ones, a Sale swimmer has taken the plunge to raise money for a charity which […]
Continue ReadingLast Updated: Tuesday 5th June, 2018